|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Reents
PRN | Corporate Officer/Principal | 59 | - |
Dana Lee
PRN | Corporate Officer/Principal | 62 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.03% | +6.41% | +11.83% | +38.36% | 49.06B | ||
| -0.73% | -0.41% | +48.84% | +36.72% | 44.6B | ||
| +1.36% | +6.03% | +343.85% | +638.73% | 43.24B | ||
| -0.47% | -0.76% | +9.75% | +103.07% | 41.73B | ||
| +0.34% | -1.38% | +5.53% | +47.36% | 29.93B | ||
| +1.00% | -1.28% | +24.23% | +156.93% | 17.19B | ||
| -2.94% | +6.98% | +5.10% | - | 15.35B | ||
| -3.20% | -2.38% | +25.00% | +43.67% | 15.54B | ||
| -0.86% | -4.00% | - | - | 15.11B | ||
| Average | -0.53% | +1.76% | +59.27% | +152.12% | 30.19B | |
| Weighted average by Cap. | -0.24% | +2.17% | +74.36% | +166.74% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















